Badilini F, Vaglio M, Sarapa N Automatic extraction of ECG strips from continuous 12-lead holter recordings for QT analysis at prescheduled versus optimized time points. Ann Noninvasive Electrocardiol. 2009 Jan;14 Suppl 1:S22-9. doi: 10.1111/j.1542-474X.2008.00260.x.
Chang RK, Rodriguez S, Gurvitz MZ Electrocardiogram screening of infants for long QT syndrome: survey of pediatric cardiologists in North America. J Electrocardiol. 2010 Jan-Feb;43(1):4-7. doi: 10.1016/j.jelectrocard.2009.07.004. Epub .
Chatrath R, Bell CM, Ackerman MJ Beta-blocker therapy failures in symptomatic probands with genotyped long-QT syndrome. Pediatr Cardiol. 2004 Sep-Oct;25(5):459-65. Epub 2004 Jul 30.
Chatrath R, Porter CB, Ackerman MJ Role of transvenous implantable cardioverter-defibrillators in preventing sudden cardiac death in children, adolescents, and young adults. Mayo Clin Proc. 2002 Mar;77(3):226-31.
Choi GR, Porter CB, Ackerman MJ Sudden cardiac death and channelopathies: a review of implantable defibrillator therapy. Pediatr Clin North Am. 2004 Oct;51(5):1289-303. Review.
Gajewski KK, Saul JP Sudden cardiac death in children and adolescents (excluding Sudden Infant Death Syndrome). Ann Pediatr Cardiol. 2010 Jul;3(2):107-12. doi: 10.4103/0974-2069.74035.
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009 Apr;42(2):377-81. doi: 10.1016/j.jbi.2008.08.010. Epub 2008 Sep 30.
Howard PA Azithromycin-induced proarrhythmia and cardiovascular death. Ann Pharmacother. 2013 Nov;47(11):1547-51. doi: 10.1177/1060028013504905. Review.
Huang H, Amin V, Gurin M, Wan E, Thorp E, Homma S, Morrow JP Diet-induced obesity causes long QT and reduces transcription of voltage-gated potassium channels. J Mol Cell Cardiol. 2013 Jun;59:151-8. doi: 10.1016/j.yjmcc.2013.03.007. Epub 2013 Mar 19.
Meyer JS, Mehdirad A, Salem BI, Kulikowska A, Kulikowski P Sudden arrhythmia death syndrome: importance of the long QT syndrome. Am Fam Physician. 2003 Aug 1;68(3):483-8. Review. Erratum in: Am Fam Physician. 2004 May 15;69(10):2324.
Saul JP, Schwartz PJ, Ackerman MJ, Triedman JK Rationale and objectives for ECG screening in infancy. Heart Rhythm. 2014 Dec;11(12):2316-21. doi: 10.1016/j.hrthm.2014.09.047. Epub 2014 Sep 18. Review.
Schwartz PJ, Ackerman MJ, George AL Jr, Wilde AA Impact of genetics on the clinical management of channelopathies. J Am Coll Cardiol. 2013 Jul 16;62(3):169-80. doi: 10.1016/j.jacc.2013.04.044. Epub 2013 May 15. Review.
Schwartz PJ, Crotti L Can a message from the dead save lives? J Am Coll Cardiol. 2007 Jan 16;49(2):247-9. Epub 2006 Dec 29.
Schwartz PJ Electrocardiography first for reducing cot death. Lancet. 2001 Aug 25;358(9282):672-3.
Schwartz PJ Management of long QT syndrome. Nat Clin Pract Cardiovasc Med. 2005 Jul;2(7):346-51. Review.
Schwartz PJ Pro: Newborn ECG screening to prevent sudden cardiac death. Heart Rhythm. 2006 Nov;3(11):1353-5. Epub 2006 Oct 10. Review.
Schwartz PJ The congenital long QT syndromes from genotype to phenotype: clinical implications. J Intern Med. 2006 Jan;259(1):39-47. Review.
Seeb JE, Pascal CE, Ramakrishnan R, Seeb LW SNP genotyping by the 5'-nuclease reaction: advances in high-throughput genotyping with nonmodel organisms. Methods Mol Biol. 2009;578:277-92. doi: 10.1007/978-1-60327-411-1_18.
Shen GQ, Abdullah KG, Wang QK The TaqMan method for SNP genotyping. Methods Mol Biol. 2009;578:293-306. doi: 10.1007/978-1-60327-411-1_19.
Skinner JR, Van Hare GF Routine ECG screening in infancy and early childhood should not be performed. Heart Rhythm. 2014 Dec;11(12):2322-7. doi: 10.1016/j.hrthm.2014.09.046. Epub 2014 Sep 18. Review.
Stanley K Design of randomized controlled trials. Circulation. 2007 Mar 6;115(9):1164-9. Review.
Tester DJ, Ackerman MJ Postmortem long QT syndrome genetic testing for sudden unexplained death in the young. J Am Coll Cardiol. 2007 Jan 16;49(2):240-6. Epub 2006 Dec 29.
Tester DJ, Ackerman MJ Sudden infant death syndrome: how significant are the cardiac channelopathies? Cardiovasc Res. 2005 Aug 15;67(3):388-96. Review.
Van Hare GF, Perry J, Berul CI, Triedman JK Cost effectiveness of neonatal ECG screening for the long QT syndrome. Eur Heart J. 2007 Jan;28(1):137; author reply137-9. Epub 2006 Dec 8.
van Langen IM, Wilde AA Con: Newborn screening to prevent sudden cardiac death? Heart Rhythm. 2006 Nov;3(11):1356-9. Epub 2006 Oct 11. Review.
Zhang Y, Post WS, Dalal D, Blasco-Colmenares E, Tomaselli GF, Guallar E Coffee, alcohol, smoking, physical activity and QT interval duration: results from the Third National Health and Nutrition Examination Survey. PLoS One. 2011 Feb 28;6(2):e17584. doi: 10.1371/journal.pone.0017584.
Zou KH, O'Malley AJ, Mauri L Receiver-operating characteristic analysis for evaluating diagnostic tests and predictive models. Circulation. 2007 Feb 6;115(5):654-7. Review.
ECG Device for Long QT Syndrome Screening in Newborns
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.